This valuable study uses mathematical modeling and analysis to address the question of how neural circuits generate distinct low-dimensional, sequential neural dynamics that can change on fast, ...
News-Medical.Net on MSN
Study compares the kidney, cardiovascular and mortality risks of three different GLP-1 RAs
Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent ...
News-Medical.Net on MSN
Study compares GLP-1 drug benefits and finds substantial variation in clinical effects
GLP-1 receptor agonists improve glycaemic control and provide renal, metabolic, and selective cardiovascular benefits in people with type 2 diabetes, based on an umbrella review of 17 meta-analyses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results